Preliminary data from the investigators' National Center for Complementary and Alternative Medicine (NCCAM)-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved self-regulation and medication adherence. This randomized, controlled trial will help the investigators to better understand the specific impact of MBSR on HIV medication and treatment adherence in HIV-infected youth, and the efficacy of MBSR in the amelioration of stress and improved self-regulation.
Despite remarkable advances in HIV medication effectiveness, adherence to HIV treatment recommendations is alarmingly poor, resulting in preventable morbidity and mortality. It is estimated that 26-72% of HIV-infected adolescents are non-adherent to their HIV medications and 22-33% are non-adherent with scheduled health care visits. HIV treatment non-adherence puts individuals at markedly increased risk for illness related to HIV itself and a variety of opportunistic infections, as well as at increased risk of spreading HIV. Preliminary data from the investigators' NCCAM-funded R21 on mindfulness-based stress reduction (MBSR) in HIV-infected youth suggest an association between mindfulness and improved medication adherence, as well as enhanced self-regulatory processes (coping, psychological function, and cognitive function). This two-armed randomized, controlled trial will help the investigators to better understand the specific impact of MBSR on HIV medication and treatment adherence in HIV-infected youth, and the efficacy of MBSR in the amelioration of stress and improved self-regulation. The aims of the study are as follows: Primary Objective Investigators hypothesize that MBSR vs. active control program (HT) participation will be associated with: • (H1) Improved HIV medication adherence (self-report validated by HIV viral load) at 3 months, 6 months, and 12 months Secondary Objectives Investigators also hypothesize that MBSR vs. active control program (HT) participation will be associated with: * (H2) Improved coping at 3, 6, and 12 months * (H3) Improved psychological functioning at 3, 6, and 12 months * (H4) Improved cognitive functioning at 3, 6, and 12 months Investigators will also explore: * associations (and potential mediation) among mindfulness, self-regulation, and HIV medication adherence and * using qualitative methods, experience with MBSR, HIV treatment adherence, as well as reasons for non-participation in the study and non-attendance of program sessions to inform future implementation planning. * gender differences in the effects of MBSR versus HT on emotion regulation and physiological responses to stressful stimuli.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
97
Mindfulness-based stress reduction, as described previously.
Health education curriculum, as described previously
University of Maryland Medical Center
Baltimore, Maryland, United States
Johns Hopkins Harriet Lane Clinic
Baltimore, Maryland, United States
Change in Treatment Adherence
Assessment of impact of MBSR versus HT on treatment adherence as measured by the Adolescent Medicine Trials Network (ATN) HIV Medication Adherence self-report measure, as well as CD4 and viral load counts pulled from the participant's medical record. The measure and medical record data collection takes place at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
NIH Emotion Measures Questionnaire
Assessment of impact of MBSR versus HT on emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up. Specific NIH emotion measures are: meaning \& purpose, positive affect, anger, fear, perceived hostility, sadness.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Illness Cognition (IC) Scale
Assessment of impact of MBSR versus HT on thoughts of illness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Difficulties in Emotion Regulation Scale (DERS)
Assessment of impact of MBSR versus HT on issues in emotion regulation measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Mindful Acceptance and Awareness Scale (MAAS)
Assessment of impact of MBSR versus HT on mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Five Facet Mindfulness Questionnaire (FFMQ)
Assessment of impact of MBSR versus HT on multiple aspects of mindfulness measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Differential Emotions Scale (DES) - selected items
Assessment of impact of MBSR versus HT on frequency of emotions (specifically, self-hostility, shame, shyness, and guilt) measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
State-Trait Anger Expressivity Inventory (STAXI)
Assessment of impact of MBSR versus HT on anger expression measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Children's PTSD Symptom Severity Checklist (CPSS)
Assessment of impact of MBSR versus HT on trauma symptoms measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Compassion Scale
Assessment of impact of MBSR versus HT on self-compassion measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Perceived Stress Scale (PSS)
Assessment of impact of MBSR versus HT on perceived stress measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Sex Risk Scale
Assessment of impact of MBSR versus HT on risky sexual behavior measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Lesbian & Gay Identity Scale (LGIS)
Assessment of impact of MBSR versus HT on self-acceptance of lesbian/gay/bisexual identity measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
General Health Assessment
Assessment of impact of MBSR versus HT on general health measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Youth Quality of Life scale (YQOL)
Assessment of impact of MBSR versus HT on quality of life measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Brief COPE Questionnaire
Assessment of impact of MBSR versus HT on coping measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Children's Response Style Questionnaire (CRSQ)
Assessment of impact of MBSR versus HT on coping responses measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Das-Naglieri Cognitive Assessment System (CAS)
Assessment of impact of MBSR versus HT on cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
Emotion Stroop Task
Assessment of impact of MBSR versus HT on emotion-based cognitive functioning measured at baseline, post-program (3-month follow-up), 6-month follow-up, and 12-month follow-up.
Time frame: Baseline, and follow up at 3, 6, and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.